India’s Latest Patent Brawl Takes Another Twist As Natco Challenges BMS
This article was originally published in PharmAsia News
Executive Summary
Natco claims its product does not infringe on Bristol’s patent for Sprycel, and that it did not defy a court order by launching its product in India.